Charles Haaser
Financieel Directeur/CFO bij YIELD10 BIOSCIENCE, INC.
Vermogen: 33 666 $ op 30-04-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Carl Guild | M | 80 | 27 jaar | |
| Oliver Peoples | M | 66 | 32 jaar | |
| Lynne Brum | F | 60 | 13 jaar | |
| Robert van Nostrand | M | 67 | 18 jaar | |
| Andrew Greenfield | M | 51 | 19 jaar | |
| Anthony Sinskey | M | 83 | 32 jaar | |
| Thomas Peoples | M | 75 | 26 jaar | |
| Thorsten Sieß | M | - | 19 jaar | |
| Richard Hamilton | M | 61 | 7 jaar | |
| Sherri Brown | M | 63 | 4 jaar | |
| Willie Loh | M | 69 | 2 jaar | |
| Kristi Snell | M | 56 | 27 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Joseph H. Shaulson | M | 58 | 7 jaar | |
| Michael P. Malone | M | 64 | 25 jaar | |
| Jay Kouba | M | 71 | 8 jaar | |
| Daniel Joseph Sutherby | M | 60 | 2 jaar | |
| Joseph D. Hill | M | 61 | 6 jaar | |
| Matthew Strobeck | M | 51 | 11 jaar | |
| Johan van Walsem | M | 61 | 15 jaar | |
| Michael Minogue | M | 57 | 18 jaar | |
| Richard P. Eno | M | 63 | 6 jaar | |
| Dorothy Puhy | F | 71 | 19 jaar | |
| Peter Kellogg | M | 67 | 13 jaar | |
| Louis E. Lataif | M | 84 | 10 jaar | |
| John Thero | M | 63 | 9 jaar | |
| Barbara H. Wells | M | 68 | 3 jaar | |
| Thomas Forest Farb | M | 67 |
Indevus Pharmaceuticals, Inc.
 Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | 3 jaar |
| Edward Giles | M | 87 | 19 jaar | |
| Celeste Mastin | F | 55 | 5 jaar | |
| Stephen J. Large | M | 66 | 1 jaar | |
| Mitchell B. Briskin | M | 64 | 20 jaar | |
| Matt Plano | M | - | - | |
| Max Senechal | M | 60 | - | |
| Frank Skraly | M | - | - | |
| Tichafa Munyikwa | M | - | 2 jaar | |
| Kurt W. Lewis | M | - |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | 2 jaar |
| Frank Menzler | M | 55 | - | |
| Karen Bohmert-Tatarev | M | - | - | |
| Sharie Fitzpatrick | F | - | - | |
| Robert Whitehouse | M | - | 2 jaar | |
| Robyn Hunter | F | 62 |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | 2 jaar |
| Andreas Woppmann | M | - |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | 3 jaar |
| Ty Glasgow | M | - | 3 jaar | |
| Stan Haftka | M | - | - | |
| Siva Sivasubramanian | M | - | - | |
| Paolo Sinni | M | - | 3 jaar | |
| Paul Barry Fireman | M | 80 | 18 jaar | |
| Gary L. Stickel | M | - | - | |
| Sheila Marie Flaherty | F | 59 | 1 jaar | |
| Edward E. Berger | M | 79 | - | |
| Robert T. Lessard | M | 83 | 14 jaar | |
| David Gottlieb | M | 63 | - | |
| Javier Jimenez | M | 58 | 3 jaar | |
| Raymond J. Kelley | M | - | - | |
| Christopher D. MacDonald | M | - | - | |
| Karim Benali | M | - | 2 jaar | |
| John Tucker | M | 61 |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | 5 jaar |
| James Gale | M | 74 |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | 2 jaar |
| Aninda Katragadda | M | - | - | |
| Robert E. Engle | M | 61 | - | |
| Ronald W. Dollens | M | 77 | 4 jaar | |
| David B. Sharrock | M | 87 |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | - |
| Andrew J. Ferrara | M | 84 |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | 3 jaar |
| Jack Lasersohn | M | 71 | 9 jaar | |
| Harry J. Gray | M | 104 |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | - |
| Nicholas Renegar | M | - | 2 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 66 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Charles Haaser
- Persoonlijk netwerk